In this Product Explainer Endocrinologist A/Prof Kenneth Ho explains the role of testosterone scrotal cream for male hypogonadism confirmed by clinical assessment and measurement of serum testosterone (5 mins).
In this Product Explainer Gynaecologist A/Prof Gino Pecoraro OAM explains the nomegestrol acetate/estradiol contraceptive pill including its tolerability, contraceptive mechanism, dosing and efficacy; and provides a clinical experience summary (5 mins).
According to the recently released ICD-11, female sexual dysfunction can be a result of a lack of desire (hypoactive sexual desire dysfunction or HSDD), sexual arousal dysfunction, or orgasmic dysfunction
For many years it has been mooted that not all menopausal symptoms are caused by lack of oestrogen alone. Testosterone therapy in women has been proven to improve sexual desire in carefully selected patients. It is a valid treatment in those who are distressed by their lack of sexual desire where there is no other cause obvious for this. How, what, where and in whom are the challenges faced by treating clinicians. In this learning module, some of Australia's leading experts will discuss the evidence, describe their clinical experience and provide practical advice on how best to apply this emerging therapeutic option.
Featuring leading women’s health expert, Dr Terri Foran and a discussion panel of leading experts – Prof Deborah Bateson, Prof Rod Baber and Dr Lina Safro – this masterclass covers a wide range of information on the OCP.
Women who are obese and taking the combined oral contraceptive pill have 12 to 24 times greater risk of developing a leg-vein blood clot than those not taking the pill and who are not overweight, according to a recent review of research
In this Product Explainer, Endocrinologist Prof Susan Davis AO explains the role of topical testosterone for the treatment of hypoactive sexual desire dysfunction (HSDD) in postmenopausal women (4 mins).